Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2021-03-29 / Front Immunol 2021;12:641307Curcumin encapsulation in nanostructures for cancer therapy: a 10-year overview
/in Curcuma, International Publications /von 2021-03-26 / Int J Pharm 2021 Mar;:120534Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer
/in Breast Cancer, Hyperthermia, International Publications /von 2021-03-17 / Mol Clin Oncol 2021 May;14(5):103Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review
/in Glioblastoma, Hyperthermia, International Publications /von 2021-03-13 / J Neurooncol 2021 May;152(3):419-428Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2021-03-13 / Cancers (Basel) 2021 Mar;13(6)Hyperthermia-Based Anti-Cancer Treatments
/in Hyperthermia, International Publications /von 2021-03-12 / Cancers (Basel) 2021 Mar;13(6)Cell Therapies in Bladder Cancer Management
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2021-03-10 / Int J Mol Sci 2021 Mar;22(6)Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers
/in Curcuma, International Publications /von 2021-03-07 / Biomolecules 2021 Mar;11(3)Neu in der Corona Ambulanz Köln: PCR Schnelltest
/in IOZK Aktuelles, IOZK In der Presse, IOZK Meldungen /von IOZK
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de